News
BDXB
48.16
0.00%
0.00
BECTON, DICKINSON AND COMPANY <BDX.N>: WELLS FARGO CUTS TARGET PRICE TO $275 FROM $280
Reuters · 6d ago
BUZZ-U.S. STOCKS ON THE MOVE-BorgWarner, Digital Realty, Take-Two
Reuters · 6d ago
BUZZ-U.S. STOCKS ON THE MOVE-Ralph Lauren, CoreCivic, WK Kellogg
Reuters · 11/07 15:52
Becton Dickinson and Co reports results for the quarter ended in September 30 - Earnings Summary
Reuters · 11/07 14:42
BUZZ-U.S. STOCKS ON THE MOVE-Guardant Health, AppLovin, Sarepta
Reuters · 11/07 14:22
BUZZ-Becton Dickinson climbs after Q4 results beat
Reuters · 11/07 13:18
BD SHARES UP 2.5% PREMARKET AFTER Q4 RESULTS BEAT
Reuters · 11/07 13:09
Becton Dickinson beats quarterly estimates on strength in drug-delivery devices
Reuters · 11/07 12:40
BRIEF-Becton Dickinson Q4 Adjusted EPS USD 3.81 Vs. IBES Estimate USD 3.77
Reuters · 11/07 11:30
BD REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2024 FINANCIAL RESULTS
Reuters · 11/07 11:30
BD - ISSUES FY25 REVENUE GUIDANCE INCLUDING GAAP GROWTH OF 8.9% TO 9.4%, ADJUSTED CURRENCY-NEUTRAL GROWTH OF 8.8% TO 9.3%
Reuters · 11/07 11:30
BD OUTLOOK FY 2025 GAAP REV $21.9 TO $22.1 BLN
Reuters · 11/07 11:30
BECTON DICKINSON AND CO - DECLARES QUARTERLY DIVIDEND OF $1.04 PER SHARE
Reuters · 11/07 11:25
What to Watch in the Day Ahead - Thursday, November 7
Reuters · 11/06 19:30
BD: BD AND YPSOMED COLLABORATE TO ADVANCE SELF-INJECTION SYSTEMS FOR HIGH VISCOSITY BIOLOGICS
Reuters · 10/23 10:57
BD: COMMERCIAL LAUNCH OF FIRST IN A FAMILY OF HIGH-THROUGHPUT, ROBOTICS-COMPATIBLE REAGENT KITS THAT WILL ENABLE AUTOMATION
Reuters · 10/14 10:45
BD: BD OMICS-ONE XT LIBRARY PREPARATION REAGENT KITS, HAMILTON AUTOMATED LIQUID HANDLING PLATFORM, APPLICATIONS COMMERCIALLY AVAILABLE GLOBALLY
Reuters · 10/14 10:45
Becton Dickinson agrees to settle about 38,000 hernia mesh suits
Reuters · 10/03 18:28
BD - SETTLEMENT DOES NOT INCLUDE ANY ADMISSION OF LIABILITY OR WRONGDOING, AND BD CONTINUES TO DISPUTE ALLEGATIONS IN THESE MATTERS
Reuters · 10/02 21:00
BD <BDX.N>: CITIGROUP RAISES TO BUY FROM NEUTRAL; RAISES TARGET PRICE TO $275 FROM $255
Reuters · 10/01 10:23
More
Webull provides a variety of real-time BDXB stock news. You can receive the latest news about Becton Dickinson And Co through multiple platforms. This information may help you make smarter investment decisions.
About BDXB
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.